Prediction of Smoking Abstinence in Women Living With Human Immunodeficiency Virus Infection.
Journal
Nursing research
ISSN: 1538-9847
Titre abrégé: Nurs Res
Pays: United States
ID NLM: 0376404
Informations de publication
Date de publication:
Historique:
pubmed:
25
1
2020
medline:
12
8
2020
entrez:
25
1
2020
Statut:
ppublish
Résumé
This study examined whether baseline negative emotional states (depression and anxiety) would predict craving for cigarettes and other nicotine withdrawal symptoms in early abstinence and whether those emotional states and withdrawal symptoms would predict failure in quitting smoking at 3 months postquit among U.S. women living with the human immunodeficiency virus (HIV). The study is a secondary analysis of data from two smoking cessation studies of women living with HIV. Craving for cigarettes and other withdrawal symptoms were assessed weekly with a total of 229 observations during the first 4 weeks following quit day. Descriptive statistics were used to examine baseline characteristics of the participants. A random growth curve model was used to estimate between-person differences in a within-person trend of changes in the withdrawal symptoms. A binary logistic regression analysis was performed to identify predictors of short-term smoking abstinence. Baseline anxiety was a predictor of postquit nicotine withdrawal symptoms but baseline depression was not. Neither baseline anxiety nor depression predicted postquit craving for cigarettes. Participants who received an HIV-tailored smoking cessation intervention showed a greater decline in craving symptom than those who received an attention-controlled intervention. HIV-tailored intervention and less craving predicted smoking abstinence at 3-month follow-up. Compared to an attention-controlled intervention, an HIV-tailored intervention effectively decreased craving for cigarette smoking after quitting-which effectively increased the rate of short-term smoking abstinence in women living with HIV.
Sections du résumé
BACKGROUND
This study examined whether baseline negative emotional states (depression and anxiety) would predict craving for cigarettes and other nicotine withdrawal symptoms in early abstinence and whether those emotional states and withdrawal symptoms would predict failure in quitting smoking at 3 months postquit among U.S. women living with the human immunodeficiency virus (HIV).
METHOD
The study is a secondary analysis of data from two smoking cessation studies of women living with HIV. Craving for cigarettes and other withdrawal symptoms were assessed weekly with a total of 229 observations during the first 4 weeks following quit day. Descriptive statistics were used to examine baseline characteristics of the participants. A random growth curve model was used to estimate between-person differences in a within-person trend of changes in the withdrawal symptoms. A binary logistic regression analysis was performed to identify predictors of short-term smoking abstinence.
RESULTS
Baseline anxiety was a predictor of postquit nicotine withdrawal symptoms but baseline depression was not. Neither baseline anxiety nor depression predicted postquit craving for cigarettes. Participants who received an HIV-tailored smoking cessation intervention showed a greater decline in craving symptom than those who received an attention-controlled intervention. HIV-tailored intervention and less craving predicted smoking abstinence at 3-month follow-up.
DISCUSSION
Compared to an attention-controlled intervention, an HIV-tailored intervention effectively decreased craving for cigarette smoking after quitting-which effectively increased the rate of short-term smoking abstinence in women living with HIV.
Identifiants
pubmed: 31977840
doi: 10.1097/NNR.0000000000000421
pmc: PMC7301409
mid: NIHMS1555456
doi:
Banques de données
ClinicalTrials.gov
['NCT02898597', 'NCT03289676']
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
167-175Subventions
Organisme : NCI NIH HHS
ID : U54 CA156732
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA156734
Pays : United States
Références
Clin Pharmacol Ther. 1994 Nov;56(5):483-93
pubmed: 7955812
Am J Prev Med. 2018 Jul;55(1):35-43
pubmed: 29929682
Drug Alcohol Depend. 2010 Nov 1;112(1-2):1-8
pubmed: 20561758
Psychol Rev. 1977 Mar;84(2):191-215
pubmed: 847061
Addict Behav. 1990;15(3):271-83
pubmed: 2378287
Addiction. 2017 Feb;112(2):330-339
pubmed: 27633341
AIDS Behav. 2017 Aug;21(8):2270-2282
pubmed: 28669024
Arch Gen Psychiatry. 1991 Jan;48(1):52-9
pubmed: 1984762
Biometrics. 1997 Sep;53(3):983-97
pubmed: 9333350
AIDS Behav. 2017 Jul;21(7):1975-1984
pubmed: 27942999
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Lancet HIV. 2018 Nov;5(11):e647-e655
pubmed: 30245004
Arch Gen Psychiatry. 1986 Mar;43(3):289-94
pubmed: 3954551
Nicotine Tob Res. 2013 Jan;15(1):1-10
pubmed: 22544839
Nicotine Tob Res. 2015 Apr;17(4):407-21
pubmed: 25762750
Res Nurs Health. 2008 Apr;31(2):180-91
pubmed: 18183564
Psychopharmacology (Berl). 2017 Mar;234(5):761-771
pubmed: 28028602
Nicotine Tob Res. 2019 Jul 17;21(8):1072-1078
pubmed: 29917091
Curr Dir Psychol Sci. 2009 Feb 1;18(1):16
pubmed: 20157637
Multivariate Behav Res. 1997 Oct 1;32(4):329-53
pubmed: 26777071
Addict Behav. 2015 Dec;51:93-9
pubmed: 26240944
Ann Behav Med. 2020 May 25;54(6):447-454
pubmed: 31863582
Br J Addict. 1991 Sep;86(9):1119-27
pubmed: 1932883
Tob Control. 1998 Spring;7(1):92-3
pubmed: 9706762
Curr Opin HIV AIDS. 2017 Jan;12(1):31-38
pubmed: 27607596
Cogn Behav Ther. 2018 Jul;47(4):301-314
pubmed: 29130427
Pharmacol Rep. 2018 Jun;70(3):434-438
pubmed: 29627689
Int J Womens Health. 2018 Sep 25;10:545-555
pubmed: 30288127
Am J Prev Med. 2010 Oct;39(4):345-51
pubmed: 20837285
AIDS Care. 2017 Jan;29(1):24-31
pubmed: 27435835
Ann Intern Med. 2015 Mar 3;162(5):335-44
pubmed: 25732274
Cogn Behav Ther. 2012;41(1):51-62
pubmed: 22375732
Nicotine Tob Res. 2003 Feb;5(1):13-25
pubmed: 12745503
AIDS. 2019 May 1;33(6):1083-1088
pubmed: 30946162
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Psychopharmacology (Berl). 2018 Jan;235(1):193-202
pubmed: 29022071
Addict Behav. 2009 Aug;34(8):632-5
pubmed: 19409710